IWC
PHAR

Integrated Wealth Concepts’s Pharming Group PHAR Stock Holding History

Integrated Wealth Concepts’s Portfolio PHAR Stock Details PHAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28K Buy
+380
New +$5.5K ﹤0.01% 4941

Other funds holding PHAR

MACM
MAC Alpha Capital Management Tampa, Florida $216M AUM
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
SGFG
Silver Grove Financial Group Orchard Park, New York $185M AUM 28.01% 1-Year Est. Return
NSG
Nalls Sherbakoff Group Knoxville, Tennessee $141M AUM 25.05% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM

Integrated Wealth Concepts's PHAR Position: Q2 2026 in Review

Integrated Wealth Concepts opened a new position in Pharming Group (PHAR) in Q2 2026: 380 shares worth $5.28K. The stake represents ﹤0.01% of the portfolio and ranks #4941 among its holdings.

18 funds tracked by Wall St. Rank hold PHAR as of Q2 2026.

  • Integrated Wealth Concepts held 380 shares of Pharming Group worth $5.28K as of Q2 2026.
  • Pharming Group was a new Integrated Wealth Concepts position in Q2 2026.
  • Pharming Group made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #4941 holding.
  • 18 funds tracked by Wall St. Rank held Pharming Group as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.